IPC-IMA TNSB Pharmacovigilance CME held at Chennai
Saw participation of 75 clinicians and pharmacologists
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
US FDA approves Myalept to treat rare metabolic disease
The safety and effectiveness of Myalept, an analogue of leptin made through recombinant DNA technology, were evaluated in an…
Venus bags marketing approval from Myanmar for its flagship product Elores
Research product likely to be launched in Myanmar in April
IPA-MSB and IPA-CPD organises training programme for pharmacists
The programme had a mix of lectures, interaction, demonstrations and panel discussions
Lupin receives FDA approval for generic mycobutin caps
Is indicated for the prevention of disseminated MAC disease in patients with advanced HIV infection
Almac adds new blistering technology at US facility
Simple solutions to bridge the gap between clinical and commercial packaging
Ranbaxy stops API shipments from Toansa and Dewas
Will resume after newly formed Quality & Integrity Committee examines and certifies all processes and controls at these…
Agilent Technologies introduces ICP-MS and MP-AES platforms
New systems provide unprecedented performance, value, ease of use
SIES Institute of Chromatography and Spectroscopy to organise seminar
Live demonstration will be held on GC and GCMS
Bosch holds Pharma Solid Symposium 2014 in Germany
Two-day industry meeting saw around 100 participants
Jubilant Biosys expands drug discovery alliance with Janssen Pharmaceutica
Expansion will focus on discovering NCE’s in multiple disease areas
MSD and Cipla announce India-specific strategic partnership
To co-market MSD’s raltegravir 400mg tablet, for Indian market
Cipla and MSD announce partnership to co-market MSD’s Raltegravir 400mg tablet in India
Brings together R&D and marketing excellence of individual companies to drive product access In an important development, MSD,…
CII hosts round table with US FDA Commissioner
It was on 'Role, Opportunities and Challenges of Women in Indian Pharmaceutical and Food Industries’
Key drugs market sees steady gain in share: KRChoksey Shares and Securities
Indian companies’ performance in the US formulations space was remarkable in Q3FY14
Stemade Biotech launches flexible payment option pricing plan
Endeavour is to make the painless dental stem cell preservation an affordable one
Common medicines should mimic timing of body’s natural systems to prevent side-effects: Study
According to the study pharmaceutical companies should develop novel techniques for achieving this
Interim budget disappoints pharma … yet again
Express Pharma presents industry reactions on the Interim Budget 2014
Arvind Remedies posts 67 per cent growth in net profit for Q3FY13-14 over Q3FY12-13
The net sales for 9MFY13-14 has gone up to Rs 636 crores